Better business coming in than going out: management describes the quality of new intake visibly exceeding what it is re
The model's full reasoning — Q4 2017 call → NO我们只需要根据提供的文本判断是否满足条件。管理层的言论中,是否明确对比了当前进入的业务与正在退出/被替代的业务的质量,并且这种更高质量的业务已经在发生,且未来会改善业绩。 在文本中,管理层讨论了多个方面:J&J合作、CMS报销、临床研究、合作伙伴等。但关键是要看是否有“in-versus-out quality contrast”和“turnover is real, current, and already in the numbers' future”。 管理层提到“we are guiding to total EXPAREL net product sales of between $300 million and $310 million in 2018”,并说“This range aligns with our 2017 year-over-year average daily growth rates recorded during each quarter, ranging from 6% to 10%.” 这似乎只是增长预期,没有对比新旧业务质量。 关于CMS报销,管理层说“Securing separate reimbursement for EXPAREL would create a significant opportunity for us.” 但这是未来可能发生的事,不是已经发生的。 关于J&J合作,管理层说“our collaboration with J&J continues to advance”并提到“account activation”等,但也没有明确对比新旧业务质量。 关于神经阻滞,管理层说“we remain confident that our submission provides all the information requested by FDA reviewers to support label expansion.” 但这是监管事项,不是业务质量对比。 关于合作伙伴,如Trinity、Aetna等,管理层说“we have made really good progress here over the last couple of quarters”但也没有明确说新业务比旧业务更好。 管理层提到“we are working with CMS to have EXPAREL unbundled within that draft rule.” 但这是未来。 在回答分析师问题时,管理层提到“we are not really driven by the size of the deal or the finances associated with the deal”等,但也没有明确对比。 唯一可能相关的是关于制造工艺的讨论,管理层说“we will give Swindon as much material as they can make, because it is an improved gross margin.” 这暗示新工厂的毛利率更高,但这是关于生产,不是关于业务质量。 整体上,管理层没有明确说“新进来的业务比正在退出的业务更好”这样的对比。他们谈论增长、合作、监管,但没有具体说当前正在签订的新合同或新客户比旧的好。 因此,答案应为NO。
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASB | Associated Banc-Corp | Q1 2024 | 2024-04-25 | A |
| GIII | G-III Apparel Group, Ltd. | Q4 2024 | 2024-03-14 | C |
| ALL | The Allstate Corporation | Q3 2023 | 2023-11-02 | C+ |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| OEC | Orion Engineered Carbons S.A. | Q4 2022 | 2023-02-17 | B+ |
| BBD | Banco Bradesco S.A. | Q3 2022 | 2022-11-09 | D |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| KTB | Kontoor Brands, Inc. | Q3 2021 | 2021-11-04 | A |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| ADSK | Autodesk, Inc. | Q3 2019 | 2018-11-20 | A |
| GECC | Great Elm Capital Corporation | Q3 2018 | 2018-11-13 | B |
| CUBI | Customers Bancorp, Inc. | Q3 2018 | 2018-10-26 | C+ |
| T | AT&T Inc. | Q3 2018 | 2018-10-24 | C+ |
| ESS | Essex Property Trust, Inc. | Q2 2018 | 2018-08-03 | B+ |
| MKC | McCormick & Company, Incorporated | Q2 2018 | 2018-06-28 | C+ |
| ALLY | Ally Financial Inc. | Q1 2018 | 2018-04-26 | B+ |
| ATI | Allegheny Technologies Incorporated | Q1 2018 | 2018-04-24 | B |
| HSTM | HealthStream, Inc. | Q3 2017 | 2017-10-24 | C |
| MTG | MGIC Investment Corporation | Q3 2017 | 2017-10-18 | B+ |
| BLKB | Blackbaud, Inc. | Q1 2017 | 2017-05-02 | B+ |
HSTM · Q3 2017 → YESThe question is about whether management conveys that the business they're taking in right now is of visibly higher quality than the business they're finishing or letting run off. YES The transcript shows management explicitly contrasting incoming business against outgoing: - Patient Experience: "Existing clients also continue to convert from a phone modality to email and SMS text surveying modality... This conversion trend to continue... expected to have a positive impact... on patient experience margins." (lower price, higher margin shift already happening) - Provider Solutions: "the move from installed software sales to software as service sales... challenge revenue growth... but not profitability growth" and "backlog of unimplemented customers... significantly reduced" - Laerdal/HeartCode: "the new product we believe is right now based on contracts.
GFS · Q3 2021 → YESThe question is about whether management conveys that the business they're taking in right now is of visibly higher quality than the business they're finishing or letting run off. YES The transcript shows management explicitly contrasting the incoming business with the outgoing: compute revenue is declining "as expected" due to customers shifting to smaller nodes, while "newer high-margin customer designs" are ramping in 2H 2022 to offset it. They tie this directly to mix improvement from "d differentiated solutions become a larger portion" and "feature-rich" platforms (FDX, RF SOI, silicon photonics) growing while feature-rich CMOS is flat or down. LTAs signed now carry "pricing improvements" baked in for 2022+, with new agreements committing future capacity at those better terms.
CYBR · Q3 2021 → YESThe question is about whether management conveys that the new business they're taking in is of higher quality than the old business they're replacing, and that as the old rolls off, results will impro...YES Management explicitly contrasts the incoming subscription business (new logos, SaaS bookings, Privileged Cloud, EPM) as higher-quality than the outgoing perpetual license business it is replacing. They describe it as delivering “faster type of value,” “higher lifetime value over time,” and “more users and more products faster ,” while noting that the current revenue and profitability headwind from the mix shift is “obscuring the P&L” and that results will improve once the transition completes.